Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Basal Cell × Ipilimumab × Clear all

Sponsor

Conditions

Melanoma 79 Carcinoma, Non-Small-Cell Lung 25 Neoplasms 18 Neoplasm Metastasis 13 Carcinoma, Renal Cell 13 Lung Neoplasms 11 Small Cell Lung Carcinoma 9 Prostatic Neoplasms 9 Diabetes Mellitus, Insulin-Dependent, 12 8 Pancreatic Neoplasms 7 Skin Neoplasms 6 Ovarian Neoplasms 6 Uveal Melanoma 5 Squamous Cell Carcinoma of Head and Neck 5 Mesothelioma 5 Brain Neoplasms 5 Sarcoma 4 Kidney Neoplasms 4 Head and Neck Neoplasms 4 Carcinoma, Transitional Cell 4 Carcinoma, Hepatocellular 4 Carcinoma 4 Breast Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Stomach Neoplasms 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Colorectal Neoplasms 3 Colonic Neoplasms 3

Interventions

HhAntag691 12 sonidegib 4 methyl 5-aminolevulinate 3 Photochemotherapy 3 Aminolevulinic Acid 3 tazarotene 2 IPI-926 2 Drug Evaluation 2 1-phenyl-3,3-dimethyltriazene 2 remetinostat 1 pembrolizumab 1 cemiplimab 1 Risk Factors 1 NVP-BKM120 1 Mindfulness 1 Midazolam 1 IFL protocol 1 Folfox protocol 1 Blood Specimen Collection 1 Bevacizumab 1 BF-200 ALA 1 Arsenic Trioxide 1 Anesthesia, Local 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡